Stanton Marshall S.'s Form 4 filing
Artivion, Inc. (AORT) · filed Mar 1, 2023
- Accession no.
- 0000784199-23-000044
- Filed
- Mar 1, 2023
- Trade date
- Feb 23-27, 2023
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $30.2K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stanton Marshall S.CIK 0001849615 | Officer (SVP, Clinical & MD Affair) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2023 | Common Stock | AGrant or awardAcquired | +3,770 | $0.00 | $0 | 44,218 | Direct | |
| Feb 27, 2023 | Common Stock | SSaleDisposed | −1,176 | $12.94 | −$15,217.44 | 43,042 | Direct | |
| Feb 23, 2023 | Common Stock | AGrant or awardAcquired | +7,440 | $0.00 | $0 | 50,482 | Direct | |
| Feb 27, 2023 | Common Stock | SSaleDisposed | −1,161 | $12.94 | −$15,023.34 | 49,321 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.